U.S. CRO Theorem Clinical Research is investing in its overseas infrastructure, setting up a new clinical supplies facility in Germany to speed up trials on the continent.
The facility, slated to open in Frankfurt next month, is a good manufacturing practice-compliant operation with nearly 9,000 square feet of storage space, Theorem said. Located near the Frankfurt airport, the new outpost will triple Theorem's current supplies capacity, the CRO said.
"We're excited to have the additional manufacturing and warehousing space and, more importantly, an infrastructure to deliver the flexibility our clients rely on," CEO John Potthoff said in a statement. "The new facility will enhance speed and scalability while preserving the versatility of our supply solutions."
The expansion follows a slew of partnerships for the deal-minded Theorem. Over the past two years, the Pennsylvania CRO has paired with Biomedical Systems for diagnostics, signed a deal with India's Excel Life Sciences to broaden its footprint in that country, joined Decision Driver Analytics to expand its post-market efforts, teamed up with Charles River Laboratories ($CRL) on preclinical research and reached out to Emergo to better capitalize on med tech.
- read the statement